Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Platelet Counts and Mean Platelet Volume As Markers of Clinical Severity in Sickle Cell Disease

Caroline Martins Silva, Samuel Souza Medina, MD MSc, Paula De Melo Campos, MD PhD, Fernando Ferreira Costa, MD PhD, Sara T Olalla Saad, MD PhD, Bruno Deltreggia Benites, MD PhD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-138486

Published: 2020

Journal Articles

Analysis of Metformin Effects on Bone Marrow Fibrosis and Disease Progression in Primary Myelofibrosis Patients: Preliminary Results of an Open Label Phase II Trial (FIBROMET)

Paula De Melo Campos, MD, Katia B Pagnano, MD PhD, Rubia Mancuso, Francisco Breno S. Teófilo, Juan L Coelho-Silva, BSc, MSc, Fernanda I Della Via, MSc, Leandro Luiz Lopes Freitas, MD PhD, Hernandes F. Carvalho, PhD, Fernando Ferreira Costa, MD PhD, Fabiola Traina, MD PhD, Sara T Olalla Saad, PhD

Blood (2019) 134 (Supplement_1): 554.

https://doi.org/10.1182/blood-2019-130648

Published: 2019

Journal Articles

Mutations in Triple-Negative Patients with Myeloproliferative Neoplasms

Maria Carolina Costa Melo Svidnicki, PhD, Paula De Melo Campos, MD, Moisés Alves Ferreira Filho, PhD, Caio Augusto Leme Fujiura, Tetsuichi Yoshizato, MD PhD, Hideki Makishima, MD PhD, Seishi Ogawa, MD PhD, Sara T Olalla Saad, PhD

Blood (2019) 134 (Supplement_1): 5395.

https://doi.org/10.1182/blood-2019-128764

Published: 2019

Journal Articles

Analysis of the Eligibility of Patients with Sickle Cell Disease for Palliative Care

Pedro de Oliveira Toro da Silva, Cristina Bueno Terzi, MD PhD, Antonio Luis Eiras Falcão, MD PhD, Sara T Olalla Saad, PhD, Fernando Ferreira Costa, MD PhD, Paula De Melo Campos, MD

Blood (2019) 134 (Supplement_1): 4681.

https://doi.org/10.1182/blood-2019-128884

Published: 2019

Journal Articles

The Pharmacological IGF1R-IRS1/2 Inhibitor NT157 Presents Multiple Anti-Neoplastic Effects in Myeloproliferative Neoplasms

Bruna Alves Fenerich, BSc, João Agostinho Machado-Neto, BSc, Ana Paula Nunes Rodrigues Alves, MSc, Paula De Melo Campos, MD PhD, Jaqueline Cristina Fernandes, BSc, MSc, Juan Luiz Coelho-Silva, BSc, MSc, Renata Scopim Ribeiro, BSc, MSc, Fernanda B da Silva, BSc and MSc, Priscila Santos Scheucher, PhD, Lorena Lobo Figueiredo-Pontes, MD PhD, Eduardo Magalhães Rego, MDPhD, Fabiola Traina, MD PhD

Blood (2017) 130 (Supplement 1): 1253.

https://doi.org/10.1182/blood.V130.Suppl_1.1253.1253

Published: 2017

Journal Articles

DNMT3A Is Highly Expressed in Bone Marrow Cells from Acute Myeloid Leukemia Patients

Renata Scopim Ribeiro, BSc, MSc, João Agostinho Machado-Neto, BSc, Paula De Melo Campos, MD PhD, Christopher A. Eide, Samantha L Savage, Irene Lorand-Metze, MD PhD, Cristina E. Tognon, PhD, Fernando Ferreira Costa, MD PhD, Brian J. Druker, MD, Sara Teresinha Olalla Saad, MD PhD, Fabiola Traina, MD PhD

Blood (2017) 130 (Supplement 1): 3969.

https://doi.org/10.1182/blood.V130.Suppl_1.3969.3969

Published: 2017

Journal Articles

IRS2 Inhibition Reduces Cell Proliferation and Has Cumulative Effects with Ruxolitinib in JAK2 V617F Cells

Paula De Melo Campos, MD, João Agostinho Machado-Neto, MSc, Patricia Favaro, PhD, Fernando Ferreira Costa, MD PhD, Sara Teresinha Olalla Saad, MD PhD, Fabiola Traina, MD PhD

Blood (2014) 124 (21): 3219.

https://doi.org/10.1182/blood.V124.21.3219.3219

Published: 2014

Journal Articles

Stathmin 1 Silencing Amplifies Ruxolitinib-Induced Apoptosis in JAK2 V617F Cells

João Agostinho Machado-Neto, MSc, Paula de Melo Campos, MD, Patricia Favaro, PhD, Mariana Lazarini, PhD, Adriana Silva Santos Duarte, PhD, Irene Lorand-Metze, MD PhD, Sara Teresinha Olalla Saad, MD PhD, Fabiola Traina, MD PhD

Blood (2014) 124 (21): 3229.

https://doi.org/10.1182/blood.V124.21.3229.3229

Published: 2014

Journal Articles

Nix (BNIP3L) Is Downregulated in High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia and Its Silencing Enhances Decitabine-Mediated Apoptosis

Mariana Lazarini, PhD, João Agostinho Machado-Neto, MSc, Adriana Silva Santos Duarte, PhD, Fernando V Pericole, MD, Karla Priscila Ferro, PhD, Paula de Melo Campos, MD, Fabiola Traina, MD PhD, Sara T.O. Saad, MD, PhD

Blood (2014) 124 (21): 3239.

https://doi.org/10.1182/blood.V124.21.3239.3239

Published: 2014

Journal Articles

Downregulation Of SPINT2 Expression In Stromal Cells From Myelodysplastic Syndrome Patients Increases HGF and SDF-1 Secretion and Promotes Cell-Cell Adhesion By Alteration In Integrin Expression

Fernanda Marconi Roversi, PhD, Matheus Rodrigues Lopes, MSc, João Agostinho Machado-Neto, MSc, Ana Leda Longhini, PhD, Adriana da Silva Santos Duarte, PhD, Bruna Palodetto, MSc, Flavia Adolfo Corrocher, MSc, Paula de Melo Campos, MD, Mariana Ozello Baratti, PhD, Fernando V Pericole, MD, Patricia Favaro, PhD, Fabiola Traina, M.D., Ph.D., Sara Teresinha Saad, MD, PhD

Blood (2013) 122 (21): 2763.

https://doi.org/10.1182/blood.V122.21.2763.2763

Published: 2013

Journal Articles

IRS2 Associates With JAK2 and May Be Involved In Cell Proliferation Pathways In Chronic Myeloproliferative Neoplasms

Paula de Melo Campos, MD, Joao Machado-Neto, MSc, Adriana Silva Santos Duarte, PhD, Rafaela Mendonça, Irene Lorand-Metze, MD, PhD, Fernando F. Costa, M.D., Ph.D., Sara T O Saad, MD, PhD, Fabiola Traina, M.D., Ph.D.

Blood (2013) 122 (21): 1598.

https://doi.org/10.1182/blood.V122.21.1598.1598

Published: 2013

Journal Articles

Familial Mastocytosis: Identification Of KIT K509I Mutation and Its In Vitro Sensitivity To Imatinib, Dasatinib and PKC412

Paula De Melo Campos, MD, João Agostinho Machado-Neto, MSc, Adriana Silva Santos Duarte, PhD, Renata Scopim-Ribeiro, BSc, Flavia Fonseca de Carvalho Barra, MD, José Vassallo, MD, PhD, Irene Lorand-Metze, MD, PhD, Ramon V. Tiu, MD, Fernando Ferreira Costa, MD, PhD, Sara T O Saad, MD, PhD, Fabiola Traina, M.D., Ph.D.

Blood (2013) 122 (21): 5267.

https://doi.org/10.1182/blood.V122.21.5267.5267

Published: 2013

Journal Articles

Stathmin 1 Is Involved In The Highly Proliferative Phenotype Of High-Risk Myelodysplastic Syndromes and Acute Leukemia Cells

João Agostinho Machado-Neto, MSc, Paula de Melo Campos, MD, Patricia Favaro, PhD, Mariana Lazarini, PhD, Irene Lorand-Metze, MD, PhD, Fernando Ferreira Costa, MD, PhD, Sara Teresinha Olalla Saad, MD, PhD, Fabiola Traina, MD, PhD

Blood (2013) 122 (21): 861.

https://doi.org/10.1182/blood.V122.21.861.861

Published: 2013

Journal Articles

ANKHD1 Interacts with the Proapoptotic Protein SIVA and Plays a Role in the Proliferation and Stathmin Activation of Acute Leukemia Cells.

Joao Machado-Neto, MSc, Mariana Lazarini, PhD, Patricia Favaro, PhD, Paula de Melo Campos, MD, Renata Scopim-Ribeiro, BSc, Gilberto Carlos Franchi-Junior, BSc, Alexandre Eduardo Nowill, MD, Irene Lorand-Metze, MD, PhD, Fernando Ferreira Costa, MD, PhD, Sara T. Olalla Saad, MD, PhD, Fabiola Traina, MD, PhD

Blood (2012) 120 (21): 2419.

https://doi.org/10.1182/blood.V120.21.2419.2419

Published: 2012

Journal Articles

Reduced TET2 expression in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia.

Renata Scopim-Ribeiro, BSc, Joao Machado-Neto, MSc, Paula de Melo Campos, MD, Patricia Favaro, PhD, Adriana S. S. Duarte, PhD, Valeria Visconte, PhD, Irene Lorand-Metze, MD, PhD, Fernando Ferreira Costa, MD, PhD, Jaroslaw P. Maciejewski, MD, PhD, Ramon V. Tiu, MD, Sara T. Olalla Saad, MD, PhD, Fabiola Traina, MD, PhD

Blood (2012) 120 (21): 2822.

https://doi.org/10.1182/blood.V120.21.2822.2822

Published: 2012

Journal Articles

Correlation Between IL10 and CD8 + Cells in MDS Patients Adds New Insight Into the Role of the Immune System in This Disease

Matheus Rodrigues Lopes, B.Sc., Fabiola Traina, MD, PhD, Joao Kleber Novais Pereira, B.Sc., Paula de Melo Campos, MD, Joao Machado-Neto, MSc, Sara T. Olalla Saad, MD, PhD, Patricia Favaro, PhD

Blood (2012) 120 (21): 3836.

https://doi.org/10.1182/blood.V120.21.3836.3836

Published: 2012

Journal Articles

Molecular Mutations in U2AF1 Are Most Commonly Found in Del20q Myelodysplastic Syndromes but Do Not Lead to Poor Prognosis in This Karyotypic Subtype

Ali Tabarroki, MD, Li Zhang, PhD, Valeria Visconte, PhD, Manoj Bupathi, MD, Heesun J. Rogers, MD, PhD, Hideki Makishima, MD, PhD, Fabiola Traina, MD, PhD, Betty K. Hamilton, MD, Edy Hasrouni, Michael J. Clemente, Paula de Melo Campos, MD, Hien K. Duong, MD, Anjali Advani, MD, Mikkael A. Sekeres, MD, MS, Edward A. Copelan, MD, Ramon V. Tiu, MD

Blood (2012) 120 (21): 3804.

https://doi.org/10.1182/blood.V120.21.3804.3804

Published: 2012

Journal Articles

Hematopoietic Cell Kinase (HCK) Is Highly Expressed in Myelodysplastic Syndrome (MDS) and Regulates Proliferation, Cell Cycle Progression and Hematopoietic Differentiation

Fernanda Marconi Roversi, PhD, João Machado-Neto, MSc, Bruna Palodetto, MSc, Flávia Adolfo Corrocher, MSc, Mariana Ozello Baratti, PhD, Paula de Melo Campos, MD, Fabiola Traina, MD, PhD, Sara T Olalla Saad, MD, PhD

Blood (2012) 120 (21): 3813.

https://doi.org/10.1182/blood.V120.21.3813.3813

Published: 2012

NARROW

Platelet Counts and Mean Platelet Volume As Markers of Clinical Severity in Sickle Cell Disease

Analysis of Metformin Effects on Bone Marrow Fibrosis and Disease Progression in Primary Myelofibrosis Patients: Preliminary Results of an Open Label Phase II Trial (FIBROMET)

Mutations in Triple-Negative Patients with Myeloproliferative Neoplasms

Analysis of the Eligibility of Patients with Sickle Cell Disease for Palliative Care

The Pharmacological IGF1R-IRS1/2 Inhibitor NT157 Presents Multiple Anti-Neoplastic Effects in Myeloproliferative Neoplasms

DNMT3A Is Highly Expressed in Bone Marrow Cells from Acute Myeloid Leukemia Patients

IRS2 Inhibition Reduces Cell Proliferation and Has Cumulative Effects with Ruxolitinib in JAK2 V617F Cells

Stathmin 1 Silencing Amplifies Ruxolitinib-Induced Apoptosis in JAK2 V617F Cells

Nix (BNIP3L) Is Downregulated in High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia and Its Silencing Enhances Decitabine-Mediated Apoptosis

Downregulation Of SPINT2 Expression In Stromal Cells From Myelodysplastic Syndrome Patients Increases HGF and SDF-1 Secretion and Promotes Cell-Cell Adhesion By Alteration In Integrin Expression

IRS2 Associates With JAK2 and May Be Involved In Cell Proliferation Pathways In Chronic Myeloproliferative Neoplasms

Familial Mastocytosis: Identification Of KIT K509I Mutation and Its In Vitro Sensitivity To Imatinib, Dasatinib and PKC412

Stathmin 1 Is Involved In The Highly Proliferative Phenotype Of High-Risk Myelodysplastic Syndromes and Acute Leukemia Cells

ANKHD1 Interacts with the Proapoptotic Protein SIVA and Plays a Role in the Proliferation and Stathmin Activation of Acute Leukemia Cells.

Reduced TET2 expression in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia.

Correlation Between IL10 and CD8 + Cells in MDS Patients Adds New Insight Into the Role of the Immune System in This Disease

Molecular Mutations in U2AF1 Are Most Commonly Found in Del20q Myelodysplastic Syndromes but Do Not Lead to Poor Prognosis in This Karyotypic Subtype

Hematopoietic Cell Kinase (HCK) Is Highly Expressed in Myelodysplastic Syndrome (MDS) and Regulates Proliferation, Cell Cycle Progression and Hematopoietic Differentiation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only